Glenmark Pharmaceuticals Ltd. was incorporated in the year 1977. Its today's share price is 293.8. Its current market capitalisation stands at Rs 7944.44 Cr. In the latest quarter, company has reported Gross Sales of Rs. 70091.65 Cr and Total Income of Rs.74847.79 Cr. The company's management includes Saira Ramasastry, D R Mehta, Milind Sarwate, Julio F Ribeiro, B E Saldanha, Sridhar Gorthi, Bernard Munos, Brian W Tempest, Rajesh V Desai, VS Mani, Cherylann Pinto, Glenn Saldanha, Glenn Saldanha.
It is listed on the BSE with a BSE Code of 532296 , NSE with an NSE Symbol of GLENMARK and ISIN of INE935A01035. It's Registered office is at B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, Mumbai-400026, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Arthur Andersen & Associates, Price Waterhouse, VK Bahri & Co, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP